CBUS vs. RIGL

Last updated Aug 1, 2026

CBUS (Cibus Global LLC) and RIGL (Rigel Pharmaceuticals, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 3 years, CBUS returned -54.33%/yr vs 40.40%/yr for RIGL. Their 0.18 correlation means their historical movements had little consistent relationship.

Performance

CBUS vs. RIGL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cibus Global LLC (CBUS) and Rigel Pharmaceuticals, Inc. (RIGL). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CBUS achieves a 10.92% return, which is significantly higher than RIGL's -14.06% return.

CBUS

• 1D: 0.00%
• 1M: 38.85%
• 6M: -1.03%
• YTD: 10.92%
• 1Y: 29.53%
• 3Y*: -54.33%
• 5Y*: —
• 10Y*: —
• ALL TIME*: -58.62%

RIGL

• 1D: -3.28%
• 1M: -4.93%
• 6M: 5.59%
• YTD: -14.06%
• 1Y: 68.01%
• 3Y*: 40.40%
• 5Y*: -1.65%
• 10Y*: 3.86%
• ALL TIME*: -10.60%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
CBUS Cibus Global LLC	$275.78K	$894.32K	$557.94K
RIGL Rigel Pharmaceuticals, Inc.	$11.43M	$14.01M	$13.32M

CBUS vs. RIGL - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
CBUS Cibus Global LLC	10.92%	-37.41%	-85.85%	-37.65%
RIGL Rigel Pharmaceuticals, Inc.	-14.06%	154.64%	16.00%	3.57%

Correlation

The correlation between CBUS and RIGL is 0.06, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.06
Correlation (3Y) Balances recent behavior with more history.	0.16
Correlation (All Time) Calculated using the full available price history since Jun 1, 2023	0.18

The correlation between CBUS and RIGL shifts across timeframes, from 0.06 (1 year) to 0.18 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap CBUS : $87.79M RIGL : $681.06M
EPS CBUS : -$0.26 RIGL : $18.94
PS Ratio CBUS : 174.50 RIGL : 2.36
PB Ratio CBUS : 35.47 RIGL : 1.81
Total Revenue (TTM) CBUS : $4.29M RIGL : $299.77M
Gross Profit (TTM) CBUS : -$164.00K RIGL : $279.95M
EBITDA (TTM) CBUS : -$34.28M RIGL : $125.80M

Return for Risk

CBUS vs. RIGL — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

CBUS

CBUS Risk / Return Rank: 58
CBUS Sharpe Ratio Rank: 56
CBUS Sortino Ratio Rank: 64
CBUS Omega Ratio Rank: 62
CBUS Calmar Ratio Rank: 56
CBUS Martin Ratio Rank: 54

RIGL

RIGL Risk / Return Rank: 75
RIGL Sharpe Ratio Rank: 77
RIGL Sortino Ratio Rank: 79
RIGL Omega Ratio Rank: 77
RIGL Calmar Ratio Rank: 74
RIGL Martin Ratio Rank: 68

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

CBUS vs. RIGL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cibus Global LLC (CBUS) and Rigel Pharmaceuticals, Inc. (RIGL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	CBUS	RIGL	Difference
Sharpe ratio: Return per unit of total volatility	0.28	1.07	-0.79
Sortino ratio: Return per unit of downside risk	1.22	1.97	-0.75
Omega ratio: Gain probability vs. loss probability	1.15	1.25	-0.10
Calmar ratio: Return relative to maximum drawdown	0.43	1.50	-1.07
Martin ratio: Return relative to average drawdown	0.78	2.51	-1.73

CBUS vs. RIGL - Sharpe Ratio Comparison

The current CBUS Sharpe Ratio is 0.28, which is lower than the RIGL Sharpe Ratio of 1.07. The chart below compares the historical Sharpe Ratios of CBUS and RIGL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

CBUS vs. RIGL - Drawdown Comparison

The maximum CBUS drawdown since its inception was -96.32%, roughly equal to the maximum RIGL drawdown of -99.37%. Use the drawdown chart below to compare losses from any high point for CBUS and RIGL.

Drawdown Indicators

	CBUS	RIGL	Difference
Max Drawdown Largest peak-to-trough decline	-96.32%	-99.37%	+3.05%
Max Drawdown (1Y) Largest decline over 1 year	-70.37%	-50.08%	-20.29%
Max Drawdown (3Y) Largest decline over 3 years	-94.92%	-50.76%	-44.16%
Max Drawdown (5Y) Largest decline over 5 years	—	-83.85%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-86.40%	—
Current Drawdown Current decline from peak	-93.87%	-96.55%	+2.68%
Average Drawdown Average peak-to-trough decline	-76.14%	-90.93%	+14.79%
Ulcer Index Depth and duration of drawdowns from previous peaks	39.00%	29.86%	+9.14%

Volatility

CBUS vs. RIGL - Volatility Comparison

Cibus Global LLC (CBUS) has a higher volatility of 34.53% compared to Rigel Pharmaceuticals, Inc. (RIGL) at 11.97%. This indicates that CBUS's price experiences larger fluctuations and is considered to be riskier than RIGL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CBUS	RIGL	Difference
Volatility (1M) Calculated over the trailing 1-month period	34.53%	11.97%	+22.56%
Volatility (6M) Calculated over the trailing 6-month period	88.61%	34.77%	+53.84%
Volatility (1Y) Calculated over the trailing 1-year period	108.74%	70.02%	+38.72%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	109.51%	85.52%	+23.99%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	109.51%	82.76%	+26.75%

Dividends

CBUS vs. RIGL - Dividend Comparison

Neither CBUS nor RIGL has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both CBUS and RIGL in my portfolio?

CBUS and RIGL have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CBUS or RIGL?

CBUS has higher volatility (34.53%) compared to RIGL (11.97%). In terms of maximum drawdown, CBUS dropped -96.32% vs RIGL's -99.37%.

Which has better risk-adjusted returns?

RIGL currently has the higher Sharpe Ratio (1.07 vs 0.28), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.